Animals (male C57BL6/J mice) were housed in a 12 h light-dark circle (06:00 on, 18:00 off, including a period of dawn) at constant temperature of 22 °C and a humidity of 60 rH.
Controls received standard chow (Altromin Spezialfutter, Lage, Germany, #TPF-1314: 5% fat, 4.8% disaccharide, 23% protein). HFD treated mice were fed a high fat, high sucrose diet (HFD; Altromin Spezialfutter, Lage, Germany, #105712: 35% fat, 19% disaccharide, 19% protein). HFD + Met and HFD + lateMet received the same HFD supplemented with 0,5% of metformin (
1,1-Dimethylbiguanide Hydrochloride, 97%, Sigma Aldrich, Darmstadt, Germany, #D150959). Metformin was added to the diet during the manufacturing process to assure equal distribution over the HFD. Mice had access to chow and water ad libitum unless otherwise specified.
A detailed description about the different cohorts of mice used in this study can be found in the
supplementary experimental procedures. All animal procedures were performed in accordance with the German Laws for Animal Protection and were approved by the local animal care committee (Landesamt für Natur-, Umwelt und Verbraucherschutz, LANUV, Recklinghausen, Germany; Az 37.09.298).
Schommers P., Thurau A., Bultmann-Mellin I., Guschlbauer M., Klatt A.R., Rozman J., Klingenspor M., de Angelis M.H., Alber J., Gründemann D., Sterner-Kock A, & Wiesner R.J. (2017). Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state. Molecular Metabolism, 6(7), 737-747.